| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |